glp 1 sales GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Beyond GLP-1Rs: emerging targets poised
Description
10.1155/ije/2876156 Int
What we know Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form
The share with active supply stabilizes at about 60 percent after three months and 56 percent after one year
S2CID 36908739
